Scratching the Surface of Immunotherapeutic Targets in Neuroblastoma

Publication date: 11 September 2017
Source:Cancer Cell, Volume 32, Issue 3
Author(s): Clare F. Malone, Kimberly Stegmaier
In this issue of Cancer Cell, Bosse et al. report GPC2 as a therapeutic target in neuroblastoma. They show that GPC2 is selectively expressed on the cell surface of neuroblastoma and is a dependency in this disease. Moreover, they demonstrate the therapeutic potential of an antibody-drug conjugate targeting GPC2.

Teaser

In this issue of Cancer Cell, Bosse et al. report GPC2 as a therapeutic target in neuroblastoma. They show that GPC2 is selectively expressed on the cell surface of neuroblastoma and is a dependency in this disease. Moreover, they demonstrate the therapeutic potential of an antibody-drug conjugate targeting GPC2.


from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2xXLvlB